Health
VARON Reiterates Its Commitment to Brand Value and Its Determination to Reshape the Oxygen Concentrator Industry
SEATTLE, July 28, 2023 /PRNewswire/ -- VARON
2023-07-28 22:20
2579
Dr. Dapeng Liu: ChatGPT Redefines Medical Device As AI Medical Milestones
SHANGHAI, July 28, 2023 /PRNewswire/ -- In the ever-evolving world of AI, ChatGPT has emerged as a groundbreaking technology, capturing the attention of tech enthusiasts and industry experts alike. Within a short span of time, it has presented new challenges and opportunities for transformative c...
2023-07-28 21:20
2647
Fresh2 Group Ltd. Completes Acquisition of SpeedIn INC, a Delivery Service Provider
NEW YORK, July 28, 2023 /PRNewswire/ -- Fresh2 Group Ltd., formerly AnPac Bio-Medical Science Co., Ltd. (NASDAQ: FRES) ("Fresh2," the "Company" or "we"), a company with operations inthe United States and China focused on the business-to-business e-commerce and supply chain sectors for the restaur...
2023-07-28 21:00
8043
Derm Favorite Skincare Brand COSRX's Revenue Rises 138% YoY in the First Half of 2023
LOS ANGELES, July 28, 2023 /PRNewswire/ -- COSRX, a skincare brand favored by dermatologists, has recently revealed an impressive year-on-year growth of 138% in the first half of 2023. This remarkable achievement signifies an anticipated two-fold increase by the end of 2023, further reinforcing i...
2023-07-28 21:00
2945
HANQUYOU Marks 3rd Anniversary with Brilliant Achievements
* HANQUYOU is the China-developed biosimilar with the most marketing approvals, covering 41 countries and regions * The launch of HANQUYOU kicks off the competition between Chinese pharmaceutical companies and the world's bio-pharmaceutical companies in biosimilar monoclonal antibodies * He...
2023-07-28 15:27
2747
Wuan Ankang Hospital's Innovative Tumor Treatment Attracts Many Patients
HANDAN, China, July 28, 2023 /PRNewswire/ -- In Handan City, Hebei Province, China, the Wu'an Ankang Hospital has 35-year of experience with tumor treatment. It has now become a second-class general hospital. The reason it attracts many patients from bothChina and abroad is that they practice hol...
2023-07-28 14:35
1234
Empowering Regenerative Medicine: 3A-GTP Technology Ushers in a New Epoch
Pioneering Green Energy Solutions: DrSignal Biotech and J&V Energy's Promising Alliance TAIPEI, July 27, 2023 /PRNewswire/ -- At the 2022 Healthcare Expo Taiwan, Dr.Signal Biotech showcased the remarkable 3A-GTP technology, succeeding a significant breakthrough. This technology accelerates the p...
2023-07-28 10:00
1432
2023 Tsinghua Amgen Scholars Program Kicks Off
Continuing to Empower Young Scientists SHANGHAI, July 27, 2023 /PRNewswire/ -- Recently, 2023 Amgen Scholar Program (ASP) was opened inChina, partnering with Tsinghua University, one of China's top academic institutions and influential universities. 24 undergraduates were selected as Amgen Schol...
2023-07-27 21:00
1778
HanAll Biopharma Reports Second Quarter 2023 Financial Results and Provides a Business Update
* Sales recorded KRW 41.4 billion, a 58 percent increase from the same period in 2022, due to sustained robust growth of major products in addition to milestone revenues from the progress in clinical programs of batoclimab. * Multiple clinical development milestones have been reached, includin...
2023-07-27 19:00
1955
AI Medical Service Inc. Signs Joint Research Agreement with Stanford Medicine
- AIM Is First Japanese Company to Establish Joint Research Agreement in Field of Endoscopic AI - TOKYO, July 27, 2023 /PRNewswire/ -- AI Medical Service Inc. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, has signed a joint research agreement ...
2023-07-27 14:00
1229
GC Genome enables the prognosis prediction and targeted treatment in breast cancer patients
YONGIN, South Korea, July 26, 2023 /PRNewswire/ -- GC Genome Corporation, a leading genomic diagnostics company, announced the publication of a new study in Journal of the National Cancer Institute (JNCI), shedding light on the remarkable potential of utilizing circulating tumor DNA (ctDNA) copy n...
2023-07-27 08:53
1211
PharmAbcine Announces First Patient Dosed in the Phase I Clinical Trial of Its Novel TIE2 Agonistic Antibody in nAMD
DAEJEON, South Korea, July 26, 2023 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today that the first patient has been dosed in the Phase I clinical trial of PMC-403, the Compa...
2023-07-26 20:00
1651
Samsung Biologics Reports Second Quarter 2023 Financial Results
* Recorded Q2'23 consolidated revenue of KRW 866.2 billion * Recorded Q2'23 consolidated operating profit of KRW 253.4 billion * Achieved record-high semi-annual revenue exceeding KRW 1,587.1 billion * Strong growth sustained with successful contract wins and full completion of Plant 4 set ...
2023-07-26 15:23
1950
Lunit Accelerates Expansion Across Middle East by Bringing AI Solution to Dr. Sulaiman Al Habib Medical Group, Middle East's Largest Healthcare Provider
Lunit strengthens presence in the Middle East by supplying AI-powered breast screening solution to Dr. Sulaiman Al Habib Medical Group for the next three years SEOUL, South Korea, July 26, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnosti...
2023-07-26 14:00
1515
China's Yunhong Group furthers global push on full biodegradation
WUXUE, China, July 26, 2023 /PRNewswire/ -- Recently, the economic representative office ofGuinea-Bissau was unveiled in the pan-health industrial park of Yunhong Group in Wuxue City in centralChina's Hubei Province. The company and representatives of African countries reached a series of cooper...
2023-07-26 13:07
1725
Mabwell to Present Clinical Trial Data of 2 Programs at ESMO Congress 2023
SHANGHAI, July 25, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that clinical trial data from phase I/II study for advanced solid tumor of Nectin-4-targeting ADC (9MW2821), and phase III study of Long-Acting Recombinant Hu...
2023-07-26 00:00
1859
HaemaLogiX and Peter MacCallum Cancer Centre Announce Myeloma CAR-T Phase I Clinical Trial Agreement
* HaemaLogiX and Peter MacCallum Cancer Centre have entered a collaboration agreement to develop and conduct the first Phase I human trial of HaemaLogiX's CAR-T cell therapy in patients with kappa-type myeloma * The agreement is the culmination of previous preclinical research collaboration b...
2023-07-25 19:30
1290
Foresee Pharmaceuticals Selected for Late-Breaking Oral Presentation on its Aderamastat Phase 2 Study Results at the European Respiratory Society (ERS) International Congress 2023
TAIPEI, July 25, 2023 /PRNewswire/ -- Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") announced today that the company has been selected for a late-breaking oral presentation on the positive primary outcomes of its aderamastat (FP-025) Phase 2 proof-of-concept allergic asthma study at the Euro...
2023-07-25 15:19
1848
Clarity reaches 50% recruitment milestone for Phase II SABRE prostate cancer trial
SYDNEY, July 24, 2023 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity", "the Company"), a clinical stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce the Phas...
2023-07-24 21:02
1799
BreathMo®: The New Generation ECMO system Revealed at ASAIO Conference
SUZHOU, China, July 22, 2023 /PRNewswire/ -- Last month, the American Society
for Artificial Internal Organs (ASAIO) 68th Annual Meeting
2023-07-22 17:50
2411
Week's Top Stories
Most Reposted
Brankas Launches Integrated APAC Open Banking Compliance Solution with ADVANCE.AI's eKYC Solution
[Picked up by 319 media titles]
2024-11-07 09:00
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
[Picked up by 313 media titles]
2024-11-12 09:00
DKSH Healthcare and Euris Unveil CRM & MCE Platform "ConnectPlus" to Revolutionize APAC Healthcare Distribution
[Picked up by 290 media titles]
2024-11-13 09:00
Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
[Picked up by 289 media titles]
2024-11-11 21:00
Sobot Introduces its All-in-One Solution at GITEX Global 2024
[Picked up by 289 media titles]
2024-11-12 11:00
Most Read
Brankas Launches Integrated APAC Open Banking Compliance Solution with ADVANCE.AI's eKYC Solution
2024-11-07 09:00
10141
XtalPi and Sinar Mas Multiartha Launch Strategic Partnership to Revolutionize AI Across Asia-Pacific
2024-11-07 11:34
7500
XTEP's First Mono Store in Malaysia Comes to Puchong
2024-11-07 10:08
6214
